RiverFront Investment Group’s Colgate-Palmolive CL Stock Holding History

RiverFront Investment Group’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1M	Buy	12,010 +3,263	+37%	+$285K	0.01%	227
2026 Q1	$746K	Buy	8,747 +1,672	+24%	+$149K	0.01%	226
2025 Q4	$559K	Buy	7,075 +2,459	+53%	+$193K	0.01%	221
2025 Q3	$369K	Buy	4,616 +378	+9%	+$32.2K	0.01%	240
2025 Q2	$385K	Buy	4,238 +843	+25%	+$77K	0.01%	228
2025 Q1	$318K	Buy	+3,395	New	+$304K	0.01%	229
2014 Q2	–	Sell	-273,098	Closed	-$17.7M	–	88
2014 Q1	$17.7M	Buy	273,098 +8,990	+3%	+$567K	0.47%	46
2013 Q4	$17.2M	Buy	+264,108	New	+$16.9M	0.5%	42

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

RiverFront Investment Group's CL Position: Q2 2026 in Review

RiverFront Investment Group increased its Colgate-Palmolive (CL) stake by 37% in Q2 2026, buying an estimated $285K and bringing the position to 12,010 shares worth $1.1M. The position accounts for 0.01% of the portfolio, ranked #227.

RiverFront Investment Group first reported a position in CL in Q4 2013 and has held it in 8 quarters since. The position peaked at $17.7M in Q1 2014. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.

RiverFront Investment Group held 12,010 shares of Colgate-Palmolive worth $1.1M as of Q2 2026.
RiverFront Investment Group bought 3,263 Colgate-Palmolive shares in Q2 2026, an estimated $285K.
Colgate-Palmolive made up 0.01% of RiverFront Investment Group's portfolio in Q2 2026, its #227 holding.
RiverFront Investment Group first reported a position in Colgate-Palmolive in Q4 2013 and has held it in 8 quarters since.
RiverFront Investment Group's Colgate-Palmolive position peaked at $17.7M in Q1 2014.
2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on RiverFront Investment Group's 13F filing for Q2 2026, filed 29 Jul 2026.